Finance & economics | Blood boom

The plasma trade is becoming ever-more hypocritical

Reliance on America grows, as other countries clutch their pearls

Analysis of blood plasma
Photograph: Alamy

An unusual sort of business will soon open in Shelby, North Carolina. It will take over premises previously run by a flooring company, tucked in beside shops selling clothes, paint and fast food. But it will not sell anything itself. Instead, willing donors, paid around $40 a pop, will sit connected to an apheresis machine. Over the course of an hour, the machine will extract their blood, siphon out plasma and recirculate the remaining fluid. The plasma will then be made into medicines, such as clotting factors for haemophiliacs and intravenous immunoglobulins for those suffering from autoimmune diseases.

Explore more

This article appeared in the Finance & economics section of the print edition under the headline “Blood boom”

From the August 31st 2024 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Finance & economics

China meets its official growth target. Not everyone is convinced

For one thing, 2024 saw the second-weakest rise in nominal GDP since the 1970s

Ethiopia's Prime Minister Abiy Ahmed speaks during the launch of the Ethiopian Securities Exchange in Addis Ababa, Ethiopia, on January 10th 2025

Ethiopia gets a stockmarket. Now it just needs some firms to list

The country is no longer the most populous without a bourse


Shibuya crossing in Tokyo, Japan

Are big cities overrated?

New economic research suggests so


Why catastrophe bonds are failing to cover disaster damage 

The innovative form of insurance is reaching its limits

“The Traitors”, a reality TV show, offers a useful economics lesson

It is a finite, sequential, incomplete information game

Will Donald Trump unleash Wall Street?

Bankers have plenty of reason to be hopeful